The risk or severity of adverse effects can be increased when hexetidine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when medrysone is combined with memantine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with nadolol.


The risk or severity of adverse effects can be increased when dipyridamole is combined with adenosine.


The risk or severity of adverse effects can be increased when medrysone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with benzocaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with tetracaine.


The risk or severity of adverse effects can be increased when loxapine is combined with Perospirone.


The risk or severity of adverse effects can be increased when fenbufen is combined with dexamethasone.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Desloratadine.


The risk or severity of adverse effects can be increased when codeine is combined with furazolidone.


The risk or severity of adverse effects can be increased when Posaconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when loxapine is combined with benzocaine.


The risk or severity of adverse effects can be increased when Tixocortol is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with nefazodone.


The risk or severity of adverse effects can be increased when biperiden is combined with pancuronium.


The risk or severity of adverse effects can be increased when fenbufen is combined with flunisolide.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Clevidipine.


The risk or severity of adverse effects can be increased when diflorasone is combined with physostigmine.


The risk or severity of adverse effects can be increased when biperiden is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when bepridil is combined with clozapine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when diflorasone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when chloroquine is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when mesoridazine is combined with primidone.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with quetiapine.


The risk or severity of adverse effects can be increased when phentolamine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when paramethasone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Phenelzine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when procaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when procaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when ramipril is combined with hydralazine.


The risk or severity of adverse effects can be increased when Salsalate is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Ifenprodil is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Butethal is combined with Flibanserin.


The risk or severity of adverse effects can be increased when estazolam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when citalopram is combined with Milnacipran.


The risk or severity of adverse effects can be increased when floctafenine is combined with ibuprofen.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Nebivolol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when procaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when dyclonine is combined with HEROIN.


The risk or severity of adverse effects can be increased when clozapine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when ketoprofen is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when oxymorphone is combined with lithium ion.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when pargyline is combined with isoetharine.


The risk or severity of adverse effects can be increased when butalbital is combined with phenytoin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with thiopental.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Nabilone is combined with nefazodone.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with Tixocortol.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with irbesartan.


The risk or severity of adverse effects can be increased when Nabilone is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when butabarbital is combined with tiagabine.


The risk or severity of adverse effects can be increased when butabarbital is combined with cocaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with ondansetron.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Droxicam.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with temozolomide.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Eprosartan is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when nortriptyline is combined with clonazepam.


The risk or severity of adverse effects can be increased when halothane is combined with Phenelzine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with zotepine.


The risk or severity of adverse effects can be increased when benazepril is combined with resveratrol.


The risk or severity of adverse effects can be increased when halothane is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when halothane is combined with nadolol.


The risk or severity of adverse effects can be increased when bepridil is combined with bupivacaine.


The risk or severity of adverse effects can be increased when bepridil is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when bepridil is combined with morphine.


The risk or severity of adverse effects can be increased when aspirin is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when MELPERONE is combined with clemastine.


The risk or severity of adverse effects can be increased when Spirapril is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Butethal is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when salicylamide is combined with Tixocortol.


The risk or severity of adverse effects can be increased when ropinirole is combined with Torasemide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Pizotifen is combined with Milnacipran.


The risk or severity of adverse effects can be increased when valsartan is combined with floctafenine.


The risk or severity of adverse effects can be increased when irbesartan is combined with Olsalazine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Normethadone.


The risk or severity of adverse effects can be increased when Phenelzine is combined with propofol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when prednisone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when sotalol is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when prednisone is combined with malathion.


The risk or severity of adverse effects can be increased when thiamylal is combined with halothane.


The risk or severity of adverse effects can be increased when pentoxifylline is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with thiopental.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Salsalate.


The risk or severity of adverse effects can be increased when methazolamide is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Phenelzine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with butalbital.


The risk or severity of adverse effects can be increased when Phenelzine is combined with nefazodone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when pimozide is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with suprofen.


The risk or severity of adverse effects can be increased when Micafungin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with irbesartan.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Etomidate is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with levodopa.


The risk or severity of adverse effects can be increased when Micafungin is combined with eperisone.


The risk or severity of adverse effects can be increased when tolnaftate is combined with eperisone.


The risk or severity of adverse effects can be increased when dibucaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with trimipramine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when trimeprazine is combined with sertraline.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with ambenonium.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Pizotifen.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with flunarizine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with mesalamine.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with butalbital.


The risk or severity of adverse effects can be increased when Quinine is combined with Halofantrine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with diazoxide.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when meperidine is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with quazepam.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with prazepam.


The risk or severity of adverse effects can be increased when meperidine is combined with clorazepate.


The risk or severity of adverse effects can be increased when enflurane is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with mefloquine.


The risk or severity of adverse effects can be increased when trimipramine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Olopatadine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when amifostine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with dyclonine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with meclizine.


The risk or severity of adverse effects can be increased when thioridazine is combined with brotizolam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with hydroxyzine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when dibucaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when benazepril is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when dibucaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when clonazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with pentazocine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when bromazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when clorazepate is combined with pentazocine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Lomitapide.


The risk or severity of adverse effects can be increased when procyclidine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when meperidine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when meperidine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when meperidine is combined with gabapentin.


The risk or severity of adverse effects can be increased when indapamide is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when valsartan is combined with spironolactone.


The risk or severity of adverse effects can be increased when amitriptyline is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when bupivacaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when baclofen is combined with paroxetine.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when losartan is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when secobarbital is combined with butalbital.


The risk or severity of adverse effects can be increased when losartan is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with carisoprodol.


The risk or severity of adverse effects can be increased when losartan is combined with Droxicam.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with sulpiride.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with nimodipine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Lofexidine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with maprotiline.


The risk or severity of adverse effects can be increased when Darunavir is combined with mecamylamine.


The risk or severity of adverse effects can be increased when doxepin is combined with Milnacipran.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Articaine.


The risk or severity of adverse effects can be increased when procyclidine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when prazosin is combined with terazosin.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with butalbital.


The risk or severity of adverse effects can be increased when meperidine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when betaxolol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Salsalate is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with thalidomide.


The risk or severity of adverse effects can be increased when Salsalate is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Salsalate is combined with Droxicam.


The risk or severity of adverse effects can be increased when difluprednate is combined with malathion.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with butamben.


The risk or severity of adverse effects can be increased when Salsalate is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when difluprednate is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when alclofenac is combined with desoximetasone.


The risk or severity of adverse effects can be increased when alprazolam is combined with proparacaine.


The risk or severity of adverse effects can be increased when Droxicam is combined with diflorasone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when enflurane is combined with Articaine.


The risk or severity of adverse effects can be increased when temazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Torasemide is combined with terazosin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with fenbufen.


The risk or severity of adverse effects can be increased when Artemether is combined with nisoldipine.


The risk or severity of adverse effects can be increased when etodolac is combined with paramethasone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Fludarabine.


The risk or severity of adverse effects can be increased when thiopental is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when pentazocine is combined with isoflurane.


The risk or severity of adverse effects can be increased when methazolamide is combined with quetiapine.


The risk or severity of adverse effects can be increased when CALCIUM GLUCONATE is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when topiramate is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Rufinamide is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Droxicam.


The risk or severity of adverse effects can be increased when Sacubitril is combined with ketoprofen.


The risk or severity of adverse effects can be increased when desipramine is combined with Retigabine.


The risk or severity of adverse effects can be increased when efavirenz is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when alclometasone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when diltiazem is combined with nisoldipine.


The risk or severity of adverse effects can be increased when oxazepam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Tianeptine.


The risk or severity of adverse effects can be increased when oxazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when doxepin is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when tolmetin is combined with betamethasone.


The risk or severity of adverse effects can be increased when sertraline is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when cocaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when felbamate is combined with clonazepam.


The risk or severity of adverse effects can be increased when felbamate is combined with promethazine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when temazepam is combined with butorphanol.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with epirizole.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when resveratrol is combined with budesonide.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Droxicam.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with felbamate.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when ketorolac is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when pergolide is combined with dimethyl sulfoxide.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Pramocaine.


The risk or severity of adverse effects can be increased when sertraline is combined with Milnacipran.


The risk or severity of adverse effects can be increased when methysergide is combined with mirtazapine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with topiramate.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with felodipine.


The risk or severity of adverse effects can be increased when ramipril is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with resveratrol.


The risk or severity of adverse effects can be increased when suprofen is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when trandolapril is combined with Olopatadine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with diltiazem.


The risk or severity of adverse effects can be increased when bromazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when bromazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when minocycline is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when morphine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when pentobarbital is combined with amisulpride.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when morphine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when pimozide is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when zopiclone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when zopiclone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when methadone is combined with loxapine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with clemastine.


The risk or severity of adverse effects can be increased when methadone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when methadone is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with terazosin.


The risk or severity of adverse effects can be increased when tolterodine is combined with meperidine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Masoprocol.


The risk or severity of adverse effects can be increased when pergolide is combined with josamycin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when lithium ion is combined with glutethimide.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when oxazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when oxazepam is combined with procaine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with acebutolol.


The risk or severity of adverse effects can be increased when zaleplon is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with lidocaine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with minoxidil.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with irbesartan.


The risk or severity of adverse effects can be increased when ramipril is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when phenobarbital is combined with brotizolam.


The risk or severity of adverse effects can be increased when diazepam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when zaleplon is combined with zotepine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with etizolam.


The risk or severity of adverse effects can be increased when zaleplon is combined with MELPERONE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with metyrapone.


The risk or severity of adverse effects can be increased when orphenadrine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with glyburide.


The risk or severity of adverse effects can be increased when cocaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when prazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when lisinopril is combined with azelastine.


The risk or severity of adverse effects can be increased when diazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when quazepam is combined with glutethimide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Tianeptine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with acemetacin.


The risk or severity of adverse effects can be increased when furosemide is combined with methazolamide.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Bambuterol.


The risk or severity of adverse effects can be increased when METAXALONE is combined with desipramine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with topiramate.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with indomethacin.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Vecuronium is combined with propoxyphene.


The risk or severity of adverse effects can be increased when selegiline is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when butamben is combined with Pizotifen.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when buspirone is combined with bupivacaine.


The risk or severity of adverse effects can be increased when buspirone is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with enflurane.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with clonazepam.


The risk or severity of adverse effects can be increased when buspirone is combined with Etomidate.


The risk or severity of adverse effects can be increased when Phenelzine is combined with sotalol.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Melatonin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with isoetharine.


The risk or severity of adverse effects can be increased when triamcinolone is combined with ambenonium.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when nicergoline is combined with SIMEPREVIR.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with benzocaine.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when quinapril is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with ibuprofen.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with tiapride.


The risk or severity of adverse effects can be increased when diflunisal is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with paramethasone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when alprazolam is combined with HEROIN.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with paroxetine.


The risk or severity of adverse effects can be increased when glutethimide is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Flupentixol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with rapamycin.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with decamethonium.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with ciprofloxacin.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Articaine is combined with clonidine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with amisulpride.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with efavirenz.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with levodopa.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with zonisamide.


The risk or severity of adverse effects can be increased when Arotinolol is combined with irbesartan.


The risk or severity of adverse effects can be increased when biperiden is combined with methadone.


The risk or severity of adverse effects can be increased when reserpine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with felodipine.


The risk or severity of adverse effects can be increased when acebutolol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Arotinolol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when buspirone is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with trimipramine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Mersalyl.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Cobicistat is combined with toremifene.


The risk or severity of adverse effects can be increased when nicergoline is combined with alprazolam.


The risk or severity of adverse effects can be increased when nicergoline is combined with nisoldipine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Clobetasone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when Clobetasone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Olsalazine.


The risk or severity of adverse effects can be increased when metaraminol is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when nabumetone is combined with loteprednol.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Droxicam.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when haloprogin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Milnacipran.


The risk or severity of adverse effects can be increased when nalbuphine is combined with bromazepam.


The risk or severity of adverse effects can be increased when lorazepam is combined with perphenazine.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when lorazepam is combined with levorphanol.


The risk or severity of adverse effects can be increased when doxepin is combined with moclobemide.


The risk or severity of adverse effects can be increased when Spirapril is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when methadone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when enflurane is combined with dantrolene.


The risk or severity of adverse effects can be increased when methadone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with levorphanol.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when Melatonin is combined with clonidine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when meperidine is combined with Normethadone.


The risk or severity of adverse effects can be increased when enalapril is combined with ketoprofen.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with formestane.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when carprofen is combined with acemetacin.


The risk or severity of adverse effects can be increased when metoclopramide is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Asenapine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Metipranolol.


The risk or severity of adverse effects can be increased when mesoridazine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with rivastigmine.


The risk or severity of adverse effects can be increased when thiothixene is combined with zotepine.


The risk or severity of adverse effects can be increased when Quinine is combined with dapsone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with primidone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with doxylamine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with quetiapine.


The risk or severity of adverse effects can be increased when diclofenac is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with haloperidol.


The risk or severity of adverse effects can be increased when promazine is combined with Butethal.


The risk or severity of adverse effects can be increased when hydromorphone is combined with benzocaine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when Olmesartan is combined with bumetanide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when promazine is combined with amobarbital.


The risk or severity of adverse effects can be increased when ILOPROST is combined with furosemide.


The risk or severity of adverse effects can be increased when ILOPROST is combined with tizanidine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when atenolol is combined with fosinopril.


The risk or severity of adverse effects can be increased when trazodone is combined with baclofen.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with chlormezanone.


The risk or severity of adverse effects can be increased when levorphanol is combined with bumetanide.


The risk or severity of adverse effects can be increased when levorphanol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when temazepam is combined with trazodone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with butorphanol.


The risk or severity of adverse effects can be increased when LISURIDE is combined with olanzapine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when diazepam is combined with butamben.


The risk or severity of adverse effects can be increased when nicergoline is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when LISURIDE is combined with omeprazole.


The risk or severity of adverse effects can be increased when Cangrelor is combined with Apixaban.


The risk or severity of adverse effects can be increased when reserpine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with cilazapril.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when sulfadiazine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with maprotiline.


The risk or severity of adverse effects can be increased when Masoprocol is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when HEROIN is combined with clonazepam.


The risk or severity of adverse effects can be increased when HEROIN is combined with promethazine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Perospirone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when epirizole is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when leflunomide is combined with fenbufen.


The risk or severity of adverse effects can be increased when atenolol is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Efonidipine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with decamethonium.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when methylergonovine is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when proparacaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when amphotericin b is combined with epoprostenol.


The risk or severity of adverse effects can be increased when amphotericin b is combined with clomipramine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with bepridil.


The risk or severity of adverse effects can be increased when amphotericin b is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when nitrazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when thiothixene is combined with efavirenz.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with tiapride.


The risk or severity of adverse effects can be increased when nicotinic acid is combined with atorvastatin.


The risk or severity of adverse effects can be increased when trazodone is combined with oxprenolol.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when trazodone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when codeine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when clozapine is combined with quetiapine.


The risk or severity of adverse effects can be increased when clozapine is combined with ketamine.


The risk or severity of adverse effects can be increased when furosemide is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when quazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Flupentixol.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Aliskiren.


The risk or severity of adverse effects can be increased when quazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with paroxetine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with furosemide.


The risk or severity of adverse effects can be increased when furosemide is combined with doxorubicin.


The risk or severity of adverse effects can be increased when trimetrexate is combined with flunarizine.


The risk or severity of adverse effects can be increased when cetirizine is combined with felbamate.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with captopril.


The risk or severity of adverse effects can be increased when linezolid is combined with thioridazine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with acebutolol.


The risk or severity of adverse effects can be increased when docetaxel is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with clomipramine.


The risk or severity of adverse effects can be increased when clonidine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Almotriptan is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Mometasone.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when cinnarizine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when efavirenz is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when amphotericin b is combined with nimesulide.


The risk or severity of adverse effects can be increased when methylene blue is combined with Indacaterol.


The risk or severity of adverse effects can be increased when felodipine is combined with nadolol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with ethotoin.


The risk or severity of adverse effects can be increased when Propacetamol is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when lorazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when procaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when pramipexole is combined with timolol.


The risk or severity of adverse effects can be increased when Carbetocin is combined with methyldopa.


The risk or severity of adverse effects can be increased when ibuprofen is combined with betamethasone.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Carbetocin is combined with apraclonidine.


The risk or severity of adverse effects can be increased when tiapride is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when valsartan is combined with Spirapril.


The risk or severity of adverse effects can be increased when zotepine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when propantheline is combined with Mirabegron.


The risk or severity of adverse effects can be increased when butorphanol is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when morphine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when butorphanol is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with oxybutynin.


The risk or severity of adverse effects can be increased when butorphanol is combined with triazolam.


The risk or severity of adverse effects can be increased when metoclopramide is combined with protriptyline.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when methscopolamine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when amiodarone is combined with Sacubitril.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Olmesartan is combined with ketorolac.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Icatibant.


The risk or severity of adverse effects can be increased when THYMOL is combined with gabapentin.


The risk or severity of adverse effects can be increased when fenoldopam is combined with dipyridamole.


The risk or severity of adverse effects can be increased when brotizolam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when docetaxel is combined with streptozocin.


The risk or severity of adverse effects can be increased when chlormezanone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Fospropofol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Perospirone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when diflunisal is combined with Salsalate.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with flunisolide.


The risk or severity of adverse effects can be increased when benztropine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Dronedarone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when lidocaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when triprolidine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Metixene.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when ketoprofen is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when cilnidipine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when cilnidipine is combined with phentolamine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with furosemide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with tizanidine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with amcinonide.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with thalidomide.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Ramelteon.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when triamterene is combined with bumetanide.


The risk or severity of adverse effects can be increased when triamterene is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when triamterene is combined with quinapril.


The risk or severity of adverse effects can be increased when triamterene is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with floctafenine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when alclofenac is combined with Tixocortol.


The risk or severity of adverse effects can be increased when ketorolac is combined with antipyrine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when procarbazine is combined with olanzapine.


The risk or severity of adverse effects can be increased when procarbazine is combined with methadone.


The risk or severity of adverse effects can be increased when butorphanol is combined with doxepin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with midazolam.


The risk or severity of adverse effects can be increased when diflunisal is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Apremilast.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Bortezomib is combined with acebutolol.


The risk or severity of adverse effects can be increased when meprobamate is combined with METAXALONE.


The risk or severity of adverse effects can be increased when butorphanol is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with prednisone.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Nepafenac.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Clofarabine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when procarbazine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Eletriptan.


The risk or severity of adverse effects can be increased when Vilazodone is combined with citalopram.


The risk or severity of adverse effects can be increased when Asenapine is combined with tetracaine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Lurasidone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Pramocaine is combined with felbamate.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with prazepam.


The risk or severity of adverse effects can be increased when fosinopril is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Naftifine is combined with nimodipine.


The risk or severity of adverse effects can be increased when Naftifine is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when dyclonine is combined with ondansetron.


The risk or severity of adverse effects can be increased when prazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when dyclonine is combined with tiagabine.


The risk or severity of adverse effects can be increased when acemetacin is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when dyclonine is combined with zonisamide.


The risk or severity of adverse effects can be increased when acemetacin is combined with amcinonide.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with desoximetasone.


The risk or severity of adverse effects can be increased when caffeine is combined with formoterol.


The risk or severity of adverse effects can be increased when Thioproperazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when fludiazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when ramipril is combined with floctafenine.


The risk or severity of adverse effects can be increased when isradipine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Etidocaine.


The risk or severity of adverse effects can be increased when spiramycin is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when naratriptan is combined with desipramine.


The risk or severity of adverse effects can be increased when fosinopril is combined with salicylamide.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when valsartan is combined with tolmetin.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Pizotifen.


The risk or severity of adverse effects can be increased when rapamycin is combined with lisinopril.


The risk or severity of adverse effects can be increased when sevoflurane is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Fospropofol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when reserpine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when bepridil is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when Normethadone is combined with efavirenz.


The risk or severity of adverse effects can be increased when bepridil is combined with fluvastatin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when nicergoline is combined with loratadine.


The risk or severity of adverse effects can be increased when sulpiride is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when celiprolol is combined with nicotine.


The risk or severity of adverse effects can be increased when celiprolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when nabumetone is combined with prednisone.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with Halobetasol.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with tiagabine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with ondansetron.


The risk or severity of adverse effects can be increased when fludiazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with zonisamide.


The risk or severity of adverse effects can be increased when Conivaptan is combined with metoprolol.


The risk or severity of adverse effects can be increased when Naftifine is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when apraclonidine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when valsartan is combined with betaxolol.


The risk or severity of adverse effects can be increased when QUINETHAZONE is combined with diazoxide.


The risk or severity of adverse effects can be increased when flurazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when secobarbital is combined with risperidone.


The risk or severity of adverse effects can be increased when butalbital is combined with nortriptyline.


The risk or severity of adverse effects can be increased when butalbital is combined with amoxapine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with isradipine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with prilocaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with proparacaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Halazepam.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Rotigotine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with duloxetine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with indapamide.


The risk or severity of adverse effects can be increased when sulindac is combined with dexamethasone.


The risk or severity of adverse effects can be increased when enalapril is combined with Bretylium.


The risk or severity of adverse effects can be increased when tacrolimus is combined with docetaxel.


The risk or severity of adverse effects can be increased when carvedilol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when salicylamide is combined with alclometasone.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with alclometasone.


The risk or severity of adverse effects can be increased when Ximelagatran is combined with Deferasirox.


The risk or severity of adverse effects can be increased when meprobamate is combined with scopolamine.


The risk or severity of adverse effects can be increased when Gliquidone is combined with ethanol.


The risk or severity of adverse effects can be increased when dipyridamole is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with trazodone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with mecamylamine.


The risk or severity of adverse effects can be increased when promethazine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with prednisone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Agomelatine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when fenbufen is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when rasagiline is combined with metaproterenol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with brotizolam.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Conivaptan.


The risk or severity of adverse effects can be increased when naratriptan is combined with reserpine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when miconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when zaleplon is combined with pimozide.


The risk or severity of adverse effects can be increased when Ifenprodil is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when zaleplon is combined with sertraline.


The risk or severity of adverse effects can be increased when losartan is combined with hydralazine.


The risk or severity of adverse effects can be increased when clozapine is combined with fenoldopam.


The risk or severity of adverse effects can be increased when proparacaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when fexofenadine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when prilocaine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with pancuronium.


The risk or severity of adverse effects can be increased when clozapine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when bupivacaine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with prednisone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when bupivacaine is combined with felodipine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Paliperidone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when bupivacaine is combined with irbesartan.


The risk or severity of adverse effects can be increased when Remoxipride is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when pergolide is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when bepridil is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when carisoprodol is combined with clidinium.


The risk or severity of adverse effects can be increased when Remoxipride is combined with levodopa.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with perphenazine.


The risk or severity of adverse effects can be increased when triprolidine is combined with meclizine.


The risk or severity of adverse effects can be increased when loxapine is combined with butalbital.


The risk or severity of adverse effects can be increased when levorphanol is combined with scopolamine.


The risk or severity of adverse effects can be increased when methadone is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when levorphanol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when floctafenine is combined with aspirin.


The risk or severity of adverse effects can be increased when amiodarone is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when sulconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when moclobemide is combined with droperidol.


The risk or severity of adverse effects can be increased when nicardipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with droperidol.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with clidinium.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with amisulpride.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with procaine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Perospirone.


The risk or severity of adverse effects can be increased when ILOPROST is combined with diflunisal.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with epoprostenol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with clomipramine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Melatonin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when pergolide is combined with nitric oxide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with clonazepam.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with promethazine.


The risk or severity of adverse effects can be increased when flurazepam is combined with prilocaine.


The risk or severity of adverse effects can be increased when Etomidate is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when prednisone is combined with physostigmine.


The risk or severity of adverse effects can be increased when flurazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with methyldopa.


The risk or severity of adverse effects can be increased when METAXALONE is combined with clomipramine.


The risk or severity of adverse effects can be increased when altretamine is combined with clozapine.


The risk or severity of adverse effects can be increased when codeine is combined with triprolidine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Calcium acetate is combined with ceftriaxone.


The risk or severity of adverse effects can be increased when Tavaborole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Tavaborole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with fluoxetine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with duloxetine.


The risk or severity of adverse effects can be increased when ketamine is combined with imipramine.


The risk or severity of adverse effects can be increased when ketamine is combined with loratadine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when ropinirole is combined with dipyridamole.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when clorazepate is combined with METAXALONE.


The risk or severity of adverse effects can be increased when methadone is combined with naratriptan.


The risk or severity of adverse effects can be increased when methysergide is combined with fluvastatin.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Normethadone is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when valsartan is combined with nimesulide.


The risk or severity of adverse effects can be increased when halothane is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when scopolamine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with felbamate.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with leflunomide.


The risk or severity of adverse effects can be increased when acetaminophen is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when triamterene is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Artemether is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when cilazapril is combined with tenoxicam.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with fluoxetine.


The risk or severity of adverse effects can be increased when propantheline is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when ketamine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when cilazapril is combined with ketorolac.


The risk or severity of adverse effects can be increased when ketamine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when meclizine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Caspofungin is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when pentazocine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Caspofungin is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Paliperidone.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with desipramine.


The risk or severity of adverse effects can be increased when Caspofungin is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Caspofungin is combined with manidipine.


The risk or severity of adverse effects can be increased when loteprednol is combined with fleroxacin.


The risk or severity of adverse effects can be increased when methscopolamine is combined with butorphanol.


The risk or severity of adverse effects can be increased when dibucaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when tolterodine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Aliskiren.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when procaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when flutamide is combined with prilocaine.


The risk or severity of adverse effects can be increased when alprazolam is combined with isoflurane.


The risk or severity of adverse effects can be increased when glimepiride is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with benazepril.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with selegiline.


The risk or severity of adverse effects can be increased when risperidone is combined with butamben.


The risk or severity of adverse effects can be increased when alprazolam is combined with prilocaine.


The risk or severity of adverse effects can be increased when ropinirole is combined with nimodipine.


The risk or severity of adverse effects can be increased when quinapril is combined with ibuprofen.


The risk or severity of adverse effects can be increased when mesoridazine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when ketorolac is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when nisoldipine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Sacubitril is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when floctafenine is combined with Salsalate.


The risk or severity of adverse effects can be increased when Sacubitril is combined with bumetanide.


The risk or severity of adverse effects can be increased when Mometasone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when clenbuterol is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Retigabine.


The risk or severity of adverse effects can be increased when leflunomide is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when floctafenine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when betaxolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when dantrolene is combined with clomipramine.


The risk or severity of adverse effects can be increased when secobarbital is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Agomelatine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when enalapril is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when propantheline is combined with levorphanol.


The risk or severity of adverse effects can be increased when Halazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with haloperidol.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with clomipramine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with triprolidine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with spironolactone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with selegiline.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Articaine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with indomethacin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with apraclonidine.


The risk or severity of adverse effects can be increased when trimeprazine is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when quetiapine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Droxicam is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when clomipramine is combined with ritodrine.


The risk or severity of adverse effects can be increased when timolol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when timolol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when timolol is combined with quinapril.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when ondansetron is combined with Desloratadine.


The risk or severity of adverse effects can be increased when propofol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ondansetron is combined with mepivacaine.


The risk or severity of adverse effects can be increased when trimipramine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with scopolamine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when barnidipine is combined with timolol.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with acemetacin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Articaine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with leflunomide.


The risk or severity of adverse effects can be increased when methadone is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when ketorolac is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when isoflurane is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when propofol is combined with tetracaine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with indapamide.


The risk or severity of adverse effects can be increased when perphenazine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with quetiapine.


The risk or severity of adverse effects can be increased when temazepam is combined with proparacaine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when temazepam is combined with Halazepam.


The risk or severity of adverse effects can be increased when perphenazine is combined with bromazepam.


The risk or severity of adverse effects can be increased when temazepam is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when benzocaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when fludiazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when moclobemide is combined with olanzapine.


The risk or severity of adverse effects can be increased when moclobemide is combined with methadone.


The risk or severity of adverse effects can be increased when diclofenac is combined with tenoxicam.


The risk or severity of adverse effects can be increased when pyrimethamine is combined with dapsone.


The risk or severity of adverse effects can be increased when meperidine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when diclofenac is combined with nabumetone.


The risk or severity of adverse effects can be increased when baclofen is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when diclofenac is combined with ketorolac.


The risk or severity of adverse effects can be increased when cabergoline is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when apomorphine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when cabergoline is combined with lomustine.


The risk or severity of adverse effects can be increased when cabergoline is combined with bromocriptine.


The risk or severity of adverse effects can be increased when apomorphine is combined with tretinoin.


The risk or severity of adverse effects can be increased when antipyrine is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with paramethasone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Paliperidone.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with paroxetine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with salicylamide.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Torasemide.


The risk or severity of adverse effects can be increased when Milnacipran is combined with zotepine.


The risk or severity of adverse effects can be increased when Milnacipran is combined with MELPERONE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when celecoxib is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when amobarbital is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when celecoxib is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when chloroxine is combined with eperisone.


The risk or severity of adverse effects can be increased when butorphanol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when lidocaine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when vincristine is combined with mitomycin C.


The risk or severity of adverse effects can be increased when clomiphene is combined with Ospemifene.


The risk or severity of adverse effects can be increased when sumatriptan is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Fospropofol.


The risk or severity of adverse effects can be increased when prilocaine is combined with baclofen.


The risk or severity of adverse effects can be increased when pimozide is combined with thiamylal.


The risk or severity of adverse effects can be increased when pimozide is combined with halothane.